Trial
NCT00128895
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University Medical Center Groningen
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development; Dutch Arthritis Association; Dutch Kidney Foundation
Condition
Vasculitis
Intervention
azathioprine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-13